Vincent Gendrin

1.8k total citations · 1 hit paper
46 papers, 1.0k citations indexed

About

Vincent Gendrin is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Vincent Gendrin has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 24 papers in Neurology and 9 papers in Epidemiology. Recurrent topics in Vincent Gendrin's work include Long-Term Effects of COVID-19 (21 papers), COVID-19 Clinical Research Studies (17 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Vincent Gendrin is often cited by papers focused on Long-Term Effects of COVID-19 (21 papers), COVID-19 Clinical Research Studies (17 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Vincent Gendrin collaborates with scholars based in France, Tunisia and Sweden. Vincent Gendrin's co-authors include Timothée Klopfenstein, Souheil Zayet, Quentin Lepiller, N.J. Kadiane-Oussou, L. Toko, P Royer, Pierre‐Yves Royer, Lynda Toko, N’dri Juliette Kadiane-Oussou and H. Zahra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and Journal of Medical Virology.

In The Last Decade

Vincent Gendrin

39 papers receiving 1.0k citations

Hit Papers

Features of anosmia in COVID-19 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Gendrin France 13 538 530 255 168 111 46 1.0k
Timothée Klopfenstein France 13 541 1.0× 535 1.0× 255 1.0× 168 1.0× 111 1.0× 55 1.0k
Souheil Zayet France 13 542 1.0× 551 1.0× 255 1.0× 168 1.0× 131 1.2× 71 1.1k
Quentin Lepiller France 18 329 0.6× 486 0.9× 252 1.0× 171 1.0× 328 3.0× 58 1.2k
Sammy Place Belgium 11 365 0.7× 644 1.2× 145 0.6× 96 0.6× 320 2.9× 22 1.1k
Roberto Rigoli Italy 14 100 0.2× 308 0.6× 105 0.4× 77 0.5× 207 1.9× 25 630
Antonio Muscatello Italy 16 188 0.3× 520 1.0× 18 0.1× 29 0.2× 145 1.3× 60 1.0k
Caitlin R. Wolf United States 11 526 1.0× 917 1.7× 16 0.1× 51 0.3× 94 0.8× 23 1.4k
Jae‐Phil Choi South Korea 14 528 1.0× 794 1.5× 16 0.1× 20 0.1× 182 1.6× 54 1.5k
Shahin Gaïni Denmark 16 321 0.6× 288 0.5× 19 0.1× 15 0.1× 324 2.9× 41 991
Xiao-Shuang Zheng China 6 207 0.4× 1.1k 2.1× 9 0.0× 182 1.1× 70 0.6× 8 1.4k

Countries citing papers authored by Vincent Gendrin

Since Specialization
Citations

This map shows the geographic impact of Vincent Gendrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Gendrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Gendrin more than expected).

Fields of papers citing papers by Vincent Gendrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Gendrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Gendrin. The network helps show where Vincent Gendrin may publish in the future.

Co-authorship network of co-authors of Vincent Gendrin

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Gendrin. A scholar is included among the top collaborators of Vincent Gendrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Gendrin. Vincent Gendrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zayet, Souheil, et al.. (2025). Residual Symptoms and Quality of Life After Treated Lyme Neuroborreliosis: Case-Control Study (QoLYME). Open Forum Infectious Diseases. 12(2). ofaf042–ofaf042.
2.
Klopfenstein, Timothée, Souheil Zayet, Vincent Gendrin, et al.. (2024). CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study). European Journal of Clinical Microbiology & Infectious Diseases. 43(6). 1051–1059.
3.
Zayet, Souheil, et al.. (2024). Outbreak of Mycoplasma pneumoniae pneumonia in hospitalized patients: Who is concerned? Nord Franche-Comté Hospital, France, 2023–2024. Epidemiology and Infection. 152. e46–e46. 10 indexed citations
4.
Gendrin, Vincent, et al.. (2024). Disseminated Yersinia enterocolitica infection associated to Sweet’s syndrome. BMC Infectious Diseases. 24(1). 1036–1036. 2 indexed citations
5.
Zayet, Souheil, et al.. (2023). Clinical spectrum of ocular manifestations in COVID-19: a case series. SHILAP Revista de lepidopterología. 2(2). 148–152.
6.
Zayet, Souheil, et al.. (2023). Lactobacillus rhamnosus a cause of Gram-positive rods bacteremia after prophylactic probiotic consumption. New Microbes and New Infections. 54. 101177–101177.
8.
Zayet, Souheil, Timothée Klopfenstein, Vincent Gendrin, et al.. (2023). Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021. Emerging infectious diseases. 29(11). 2 indexed citations
9.
Klopfenstein, Timothée, et al.. (2022). Pyoderma Gangrenosum as Differential Diagnosis to Post-Operative Infection after Breast Plastic Surgery. Surgical Infections. 23(6). 604–606. 2 indexed citations
10.
Zayet, Souheil, et al.. (2022). Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing. International Journal of Infectious Diseases. 124. 104–106. 3 indexed citations
11.
12.
Klopfenstein, Timothée, Vincent Gendrin, Julien Mercier, et al.. (2022). Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study. International Journal of Infectious Diseases. 119. 114–116. 2 indexed citations
14.
Belfeki, Nabil, et al.. (2021). Recurrent obstructive prostatitis revealing granulomatosis with polyangiitis. Urology Case Reports. 40. 101949–101949. 1 indexed citations
15.
Klopfenstein, Timothée, Vincent Gendrin, N’dri Juliette Kadiane-Oussou, Thierry Conrozier, & Souheil Zayet. (2021). Tocilizumab in COVID‐19 pneumonia: Practical proposals based on a narrative review of randomised trials. Reviews in Medical Virology. 32(1). e2239–e2239. 11 indexed citations
16.
Zayet, Souheil, N’dri Juliette Kadiane-Oussou, Quentin Lepiller, et al.. (2020). Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes and Infection. 22(9). 481–488. 140 indexed citations
17.
Lang, Stephan, et al.. (2020). Asymptomatic cerebral abscesses after pleuropulmonary Nocardia farcinica infection. New Microbes and New Infections. 38. 100808–100808. 4 indexed citations
18.
Lohse, Anne, Timothée Klopfenstein, Pierre‐Yves Royer, et al.. (2020). Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes and Infection. 22(9). 500–503. 14 indexed citations
19.
Klopfenstein, Timothée, Souheil Zayet, Anne Lohse, et al.. (2020). Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Médecine et Maladies Infectieuses. 50(5). 397–400. 178 indexed citations
20.
Gendrin, Vincent, et al.. (2011). Amélioration de la prescription des fluoroquinolones dans les infections urinaires. Revue de pertinence à deux tours. La Presse Médicale. 41(1). e10–e14. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026